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  ABSTRACT 
Delayed-onset muscle soreness (DOMS) is the feeling of discomfort that occurs after being exposed to 
unaccustomed eccentric resistance training often resulting in diminished athletic performance.  Previous 
research has shown positive effects with omega-3 fatty acid (O3FA) supplementation to ameliorate 
DOMS.  The purpose of this study was to investigate the effects of acute O3FA supplementation on 
perceived muscle soreness, ratings of exertion, and recovery after a lower body resistance training 
protocol in college-aged males.  A double blind, repeated-measures design was utilized with 10 healthy, 
college-age males.  Participants were placed in the placebo (olive leaf oil) or experimental (O3FA) group, 
consuming 3,000 mg O3FA for seven days.  Exercise protocol consisted of two testing sessions, separated 
by 24 hours, of the leg press, leg extension, and lying leg curl exercises at 75% 1RM completing three 
sets until failure for each exercise.  Following a seven-day washout period, participants repeated the 
protocol in the opposite supplement group.  A paired sample t-test (α = 0.05) was conducted for 1) total 
number of repetitions; 2) difference in number of repetitions; 3) perceived ratings of exertion; 4) 24-hour 
perceived muscle soreness; 5) and recovery status.  O3FA supplementation was not effective in 
improving any variable tested when compared to the placebo: total number of repetitions between 
conditions (O: 96 ± 17, C: 90 ± 24, p = 0.45); difference in repetitions between tests (O: 6 ± 12, C: 14 ± 
11, p = 0.19); RPE (Test 1: Mdn = 5.5, C: Mdn = 6.0, Z = 13.0, p = 0.86; Test 2: Mdn = 6.0, C: Mdn = 
7.0, Z = 7, p = 0.88); 24 hour perceived muscle soreness (O: 26.8 ± 21.0, C: 33.7 ± 17.6, p = 0.47); and 
recovery status (O: Mdn = 6.0, C: Mdn = 4.0, Z = 25.5, p = 0.38).  The results suggest that acute O3FA 
supplementation does not attenuate perceived muscle soreness or improve rating of exertion or recovery 
24 hours following induction of DOMS. 
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CHAPTER 1 
INTRODUCTION 
Purpose of the Study 
The purpose of this study is to investigate the effects of acute, lasting seven to ten days, omega-3 
fatty acid supplementation on perceived muscle soreness, ratings of exertion, and recovery after a lower 
body resistance training protocol in college aged males.  Past research has shown omega-3 fatty acid 
(O3FA) supplements positively influence the effects of delayed-onset muscle soreness (DOMS), but there 
is little consistency in the methods used to induce DOMS, type of O3FA used, and supplementation dose 
or supplementation period.  The information from this study may be helpful in determining whether 
O3FA supplementation could be used to accelerate recovery to a person’s baseline of sports performance. 
How This Study Is Original 
 The present study deals with a particular age level in the range of 18 to 24 and a supplement 
protocol not yet paired with a lower body exercise protocol to induce muscle soreness in known research.  
To the author’s knowledge, this is the first study observing the effects of omega-3 fatty acid 
supplementation on delayed-onset muscle soreness using perceived recovery status as an evaluation 
method during acute supplementation.  To the author’s knowledge, this is the first study evaluating total 
repetitions completed and the difference in repetitions completed between exercise training sessions with 
O3FA supplements.   The author knew that college age individuals are more susceptible to muscle 
soreness than older or younger individuals, and made the assumption that the majority of college age 
males do not regularly engage in lower body exercises or eat a diet high in fatty fish.  Each of the 
participants in the study completed a health history questionnaire and a food allergy questionnaire before 
being admitted to the study.  The participants were eligible for a raffle at the end of the study.  All of the 
participants were enrolled as full-time students at a southeastern university. 
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 Delayed-onset muscle soreness (DOMS) is the feeling of discomfort experienced by elite and 
novice athletes that occurs after being exposed to unaccustomed eccentric resistance training as well as 
high-intensity, or long-duration exercise (Serravite, Perry, Jacobs, Adams, Harriell, & Signorile, 2014).  
Symptoms of DOMS include soreness, loss of range of motion (ROM), and a decrease in strength 
production during training which can negatively affect athletic performance (Serravite et al, 2014).  
Performance-inhibiting effects attributed to DOMS reaches its peak 24 to 48 hours after exercise (Contro, 
Mancuso, Proia, 2016; Gulick, Kimura, Sitler, Paolone, Kelly IV, 1996).  Research has shown no 
evidence that the effects of DOMS from eccentric exercise are permanent, also showing that it may serve 
as a precursor to muscle adaptation with increased use (Armstrong, Warren, & Warren, 2016).   
Classified as a Type I muscle strain, DOMS is caused by unaccustomed stretching and/or 
microtrauma of the muscle tissue during eccentric exercise (Cheung, Hume, & Maxwell, 2003; Ryan, 
Long, Bishop, Herron, & Katica, 2013).  Eccentric exercise is well documented in being more effective 
than concentric or isometric exercise in generating muscle damage leading to DOMS (McHugh, 
Connolly, Eston, & Gleim, 1999).  White blood cell (WBC) concentrations increase in both eccentric and 
concentric exercise, and Bazgir, Salesi, Koushki, and Amirghofran (2015) showed there was not a 
significant difference in increased WBC concentration between the two exercise modalities when 
comparing athletes and non-athletes. 
Oxidative stress is caused by an imbalance between the production of reactive oxygen species 
(ROS) and the body’s ability to detoxify free radicals in the body (Leeuwenburgh & Heinecke, 
2001).  During exercise, ROS production is stimulated due to an increase in leukocyte production caused 
by cell damage during an inflammatory response in the body which act as mediators of inflammation 
(Leeuwenburgh & Heinecke, 2001; Sousa, Teixeira, & Soares, 2014).   The influx of calcium ions during 
an inflammatory response disrupts the sensory regulators in the sarcomeres which can play a role in the 
formation of DOMS following eccentric exercise. 
Polyunsaturated fatty acids (PUFA) are essential fatty acids (FAs) that are not synthesized in the 
body and must be obtained in the diet.  There are two classes of PUFAs, omega-3 fatty acids (O3FA) and 
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omega-6 fatty acids (O6FA) (Allam-Ndoul, Guenard, Barbier, & Vohl, 2016).  O6FA produce 
arachidonic acid (AA) which produces pro-inflammatory cytokines while O3FA produce alpha linolenic 
acid (ALA) which produces anti-inflammatory cytokines like eicosapentaenoic (EPA) and 
docosahexaenoic (DHA) acids.  EPA and DHA produce anti-inflammatory eicosanoids such as 
prostaglandins. (Allam-Ndoul, Guenard, Barbier, & Vohl, 2016).  Prostaglandins are hormones that 
reduce inflammation in the body, improve blood flow, decrease swelling, and inhibit inflammatory WBC 
recruitment (Jouris, McDaniel, & Weiss, 2011).   
Exercise-induced muscle soreness (EIMS) results from exhaustive or intense exercise that the 
body is unaccustomed to performing (Ryan, Long, Bishop, Herron, & Katica, 2013). Common symptoms 
of EIMD include a loss in force production, range of motion (ROM) and DOMS.  DOMS causes 
tenderness or stiffness in the affected limbs and loss of strength caused by a decrease in ROM.  The 
inability to effectively perform through a full ROM reduces the amount of muscle fibers recruited during 
training and competition.  Lamb (2009) states that an influx of calcium ions from the cytoplasm can result 
in soreness and disrupt the excitation-contraction coupling process decreasing muscle fiber recruitment.  
This results in decreased force production and, therefore, decreased athletic performance (Haff & Triplett, 
2016).  
O3FA can be found naturally in fatty fish, nuts, green, leafy vegetables, fortified foods, and in 
supplement form.  Fish sources include salmon, tuna, halibut, herring, and oysters (Gligor & Gligor, 
2016).  Nuts and seeds including walnuts and flaxseed are natural sources of polyunsaturated FAs (Gligor 
& Gligor, 2016).  Green, leafy vegetables, such as Brussel sprouts, kale, spinach, broccoli, and 
cauliflower are good sources of ALA (Williams, Rawson, & Branch, 2017).  Lastly, fish oils supplements 
are rich in O3FA and are the commonly used to supplement O3FA in the diet (DiLorenzo, Drager, & 
Rankin, 2014).   
The success of past research suggests that it is important to investigate the effects O3FA have on 
recovery time to determine if O3FA helps athletes not only not feel the effects of DOMS, but to also 
determine if it helps return their performance to baseline levels.  Chapman, Newton, McGuigan, and 
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Nosaka (2008) and Marginson, Rowlands, Gleeson, and Eston (2005), determined that college-age males 
(25 ± 6 years) are more likely to experience DOMS than males nine to ten years of old and elderly males 
(64 ± 4 years).  It was hypothesized that this was due to younger and older males having fewer type II 
muscle fibers compared to college-age individuals. The younger population has not gone through puberty 
and had less trained type II muscle fibers, and the elderly population may have lost type II muscle fibers 
due to sarcopenia. 
Hypothesis:  Omega-3 fatty acid supplementation will significantly reduce the effects of delayed-onset 
muscle soreness resulting in a faster recovery period. 
Rationale:  Until recently, scientific research investigating the efficacy of omega-3 fatty acid 
supplementation on the effects of DOMS has been scarce.  There are mixed results on the benefits of 
O3FA supplementation and DOMS typically depending on the supplementation and exercise protocols.  
Therefore, the purpose of this study is to investigate the effects of acute O3FA supplementation on 
perceived muscle soreness, ratings of exertion, and recovery after a lower body resistance training 
protocol.  The information from this study may be helpful in determining whether O3FA supplementation 
could be used to accelerate recovery to an athlete’s baseline of sports performance.  It is hypothesized that 
acute supplementation of O3FA at 3,000 mg per day for seven days will alleviate the effects of delayed-
onset muscle soreness.   
Limitations:  Participants between the ages of 18-24 years will be recruited from physical education 
classes at a southeastern university. In order to participate in this study, individuals must be untrained in 
resistance training exercise.  Another limitation is the supplementation protocol as there is conflicting 
research on the efficiency of acute O3FA supplementation on attenuating DOMS using acute 
supplementation protocols. 
Delimitations: Participants in the study will be college-aged (18-24 years old) students from a southeast 
university.  Criteria to participate will include individuals that are untrained in resistance training, have 
not had any lower body injuries in the last six months, and are not currently taking nonsteroidal anti-
inflammatory drugs or eating an anti-inflammatory diet. 
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Assumptions:  It will be assumed that every participant give maximal effort during all testing protocols 
and each participant will be able to perform leg extension and lying leg curl exercises. In addition, it will 
be assumed that participants will properly follow supplementation, exercise, and nutrition protocols 
throughout the duration of the study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13 
 
CHAPTER 2 
REVIEW OF LITERATURE 
EXERCISE-INDUCED MUSCLE DAMAGE 
Exercise-Induced Muscle Damage (EIMD) results from exhaustive or intense eccentric exercise 
that the body is not accustomed to performing (Sousa, Teixeira, & Soares, 2014).  Symptoms of EIMD 
include a reduction in force production and range of motion, delayed onset muscle soreness (DOMS), and 
inflammation, which all result in a decreased athletic performance (Sousa, Teixeira, & Soares, 2014).  
Proske and Allen (2005) stated that following eccentric exercise, force production is inhibited for up to a 
week though recovery is completed with two hours post-exercise.  This is likely due to muscle damage 
that is suffered during eccentric exercise.   
MECHANISMS OF EIMD 
There are three primary forms of resistance exercises; isometric, concentric, and eccentric 
exercise.  These forms of resistance training vary based on the muscle action required to perform the 
exercise.  Isometric exercise is characterized by a muscle contraction without muscle shortening or 
lengthening (Haff & Triplett, 2016; Mike, Cole, Herrera, VanDusseldorp, Kravitz, & Kerksick, 2017).  
Concentric exercise is characterized by a shorting of the muscle tissue without the eccentric, or muscle 
lengthening, phase during the exercise (Haff & Triplett, 2016).  Eccentric exercise involves a contraction, 
muscle shortening, and an eccentric phase and is the type of exercise most commonly associated with 
DOMS (Mike, Cole, Herrera, VanDusseldorp, Kravitz, & Kerksick, 2017).  
According to Proske and Allen (2005), a primary cause of DOMS stems from instability in the 
sarcomere length-tension curve.  It was stated that during the eccentric phase of resistance training, some 
overlapping sarcomeres in the muscle fiber resist the lengthening of the muscle to the detriment of weaker 
sarcomeres that become stretched more frequently than others.  Over time, these weaker sarcomeres 
become overstretched causing stronger sarcomeres to do more work causing those to also become 
overstretched.  This causes a disruption of one or more sarcomere resulting in the disruption of adjacent 
sarcomeres and myofibrils causing muscle damage.  If this occurs, membrane damage of the sarcoplasmic 
14 
 
reticulum will result due to structural damage caused by the prevalence of overstretched sarcomeres.  
While structural distortions to the sarcomeres and myofibrils are occurring during eccentric training, 
intracellular calcium (Ca2+) moves into the sarcoplasm which begins the next stage of the damage 
process. 
Another theory suggested by Proske and Allen (2005) suggests that muscle damage is caused by 
changes in the excitation-contraction (E-C) uncoupling caused by intracellular Ca2+ movement into the 
sarcomere.  However, this theory does not explain changes in the length-tension relation of the muscle, 
which can lead to increases in muscle length. 
A popular theory regarding the secondary mechanisms of EIMD points to the role of Ca2+ influx 
into the muscle cell caused by muscle damage.  An excessive influx of Ca2+, caused by an increased 
permeability of the sarcolemma, leading to an accumulation of Ca2+ in the muscle cell is involved in 
various processes that lead to muscle cell damage and DOMS (Gissel, 2005).  An increase in intracellular 
Ca2+ activates PLA2 which attacks the mitochondria as well as other membrane phospholipids releasing 
free fatty acids, such as arachidonic acid (Gissel, 2005; Connolly, Sayers, & McHugh, 2003).  
Arachidonic acid may increase reactive oxygen species (ROS) production damaging cell structures, which 
will stimulate an inflammatory response in muscle cells leading to DOMS. 
INFLAMMATORY MECHANISMS 
Each of the theories regarding the primary and secondary mechanisms of EIMD ultimately leads 
to an inflammatory response in the muscle cell.  Phospholipase A2 production results in arachidonic acid 
being separated from the cell membrane and signals the production of eicosanoids (prostaglandins, 
thromboxanes, and leukotrienes), which amplify the initial signs of inflammation (Serhan, Chiang & Van 
Dyke, 2008; Connolly, Sayers, & McHugh, 2003).  Prostaglandin E2 is responsible for the sensation of 
pain during DOMS by stimulating type III and IV pain receptors while leukotrienes attract neutrophils to 
the site of damage (Connolly, Sayers, & McHugh, 2003).  Neutrophils will enter damaged tissue causing 
further damage by stimulating the production of free radicals during phagocytosis (Connolly, Sayers, & 
McHugh, 2003).  The production of eicosanoids is upregulated by the production of pro-inflammatory 
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cytokines [tumor necrosis factor-alpha (TNF-alpha), interleukin-1 (IL-1), and interleukin-6 (IL-6)] after 
exercise (MacIntyre, Reid, & McKenzie, 1995).  These cytokines play various roles in the body including 
facilitating the influx of lymphocytes, neutrophils, and monocytes into the cell to clear antigens and begin 
healing damaged tissue (Ostrowski, Rhode, Asp, Schjerling, Pedersen, 1999).  TNF-alpha and IL-1 share 
similar roles in the body in that they are responsible for the production of acute-phase response and fever 
following exercise as well as and both can stimulate the release of IL-6.  IL-6 is released when nerve 
injuries have occurred and has been shown to play a role in nerve regeneration by inducing apoptosis of 
neutrophils and macrophages (Zhang & An, 2007; MacIntyre, Reid, & McKenzie, 1995; Bucci, 2000).  
DELAYED-ONSET MUSCLE SORENESS 
DOMS, classified as a type I muscle strain, shows symptoms including tenderness or stiffness in 
the affected limb, loss of strength and range of motion, and soreness (Cheung, Hume, & Maxwell, 2003; 
Serravite, Perry, Jacobs, Adams, Harriell, & Signorile, 2014).  Symptoms begin approximately 8 hours 
following exercise, reach their peak between 24 to 48 hours following unaccustomed exercise, and 
progressively decrease with time (Sayers, Dannecker, 2004; Cheung, Hume, & Maxwell, 2003). 
In 2005, a study by Cleary and Kendrick (2005) investigated the effects of hydration status on 
DOMS and muscular strength in ten healthy males between the ages of 18 and 35 who regularly engaged 
in lower body exercise within the last six months.  Participants performed a heat-stress test by walking in 
a controlled hot, humid environment for 60 minutes.  The euhydrated group was permitted to drink water 
during the exercise protocol while the dehydrated group was fluid restricted to induce dehydration.  
Following the heat-stress trial, participants underwent a DOMS-inducing workout consisting of a 45-
minute downhill run and were evaluated for DOMS within 60 minutes of the downhill run.  In the study, 
muscular strength was significantly (p < 0.05) less in the dehydrated group by 10.5% 24 hours following 
exercise.  There was also a significant increase in DOMS in the fluid restricted group (p < 0.001) at 24- 
and 48-hours following exercise protocol.  Theories regarding the causes of EIMD and DOMS suggest an 
increase in inflammation of muscle tissue.  Results of this study concluded that hydration status affects 
perceived soreness and muscle strength following eccentric exercise.  It also showed that higher ratings of 
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perceived soreness accompanied a decrease in muscle strength 24 hours when compared to 72- and 96-
hours following exercise.  
ELICITING DOMS 
To date, the majority of studies examining the effects or treatment of DOMS use eccentric 
exercise to induce soreness with most of the subjects participants being untrained or recreationally trained 
college-aged volunteers as it elicits a greater response to DOMS than professionally trained athletes 
(Ryan, Bishop, Herron, & Katica, 2013; Serravite, Perry, Jacobs, Adams, Harriell, & Signorile, 2014; 
Mike, Cole, Herrera, VanDusseldorp, Kravitz, & Kerksick, 2017; Houghton, & Onambele, 2012; Nosaka 
& Newton, 2002; Corder, Newsham, McDaniel, Ezekiel, & Weiss, 2016; Gray, Chappell, Jenkinson, 
Thies, & Gray, 2014).  Though these studies used untrained or recreationally trained individuals, not all 
exercise protocols elicited an adequate DOMS response following exercise.   
Age appears to be an important factor to consider when eliciting DOMS because college age 
individuals (18 to 24 years) are more likely to develop DOMS than older or younger individuals.  
Chapman, Newton, McGuigan, and Nosaka (2008) compared the reaction of DOMS between college-
aged (25 ± 6 years; n = 10) and older (64 ± 4 years; n = 10) men following eccentric exercise.  With the 
exception of age, no other demographic profiles were significantly (p < 0.05) different between groups.  
Participants were untrained individuals engaging in less than one structured resistance training session in 
the previous six months.  Both groups completed five sets of six maximal lengthening bicep curl 
contractions with 90 seconds of rest between sets.  Total work performed was not significantly (p > 0.05) 
different between groups though the old group had a greater (p > 0.05) decline in strength one hour 
following exercise.  24 to 72 hours following exercise, perceived muscle soreness was significantly lower 
(p > 0.05) in the old group than the young group.  Based on the findings of this study, it was concluded 
that college-aged individuals are more likely to experience DOMS than older individuals. 
In a similar study, Marginson, Rowlands, Gleeson, and Eston (2005) investigated the effects of 
DOMS on college-aged and younger individuals.  10 young boys (9.9 ± 0.3 years) and 10 men (22.2 ± 2.7 
years) completed eight sets of ten plyometric jumps to induce DOMS two times, separated by two weeks.  
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Isometric strength of the quadriceps and perceived soreness were measured 30 minutes, 24 hours, 48 
hours, and 72 hours following exercise. Perceived soreness was significantly (p < 0.05) higher in men at 
30 minutes, 24, 48, and 72 hours following exercise in both bouts and a significant (p < 0.05) decrease in 
strength was observed in men at the same intervals.  Perceived soreness for the younger group was 
significantly increased 30 minutes and 24 hours following exercise in the first bout and no significance (p 
< 0.05) was observed in the second bout for either soreness or isometric strength.  It was concluded that 
college-aged men were more likely to experience the effects of DOMS, including perceived soreness and 
less of strength than younger individuals following damage inducing exercise. 
In both studies, it was concluded that a difference in type of muscle fiber type and number of type 
II muscle fibers caused the difference in soreness as type II muscle fibers are more susceptible to 
soreness.  Type II muscle fibers are less developed in prepubescent boys whereas older men may have 
fewer type II muscle fibers due to sarcopenia (Chapman, Newton, McGuigan, & Nosaka, 2008).  
To further support the role of type II muscle fibers in eliciting DOMS, Macaluso, Isaacs, and 
Myburgh (2012) tested eight untrained individuals (22 ± 1 years) by performing ten sets of ten squat-
jumps with one minute of rest in between sets.  The purpose of this study was to determine the percent of 
muscle fibers utilized in an eccentric exercise.  Perceived soreness of the knee extensor was measured 
using a VAS, and a muscle biopsy of the vastus lateralis was performed to measure what muscle fibers 
were damaged following eccentric exercise.  All participants completed ten sets of ten squat jumps with 
one minute of rest between sets.  Creatine kinase levels increased, but were not significant, and remained 
elevated for one day following exercise.  Perceived soreness from squat jumps increased (p < 0.05) 6 
hours following exercise and peaked at two days.  Results found that 7.6% of type I fibers, 10.3% of type 
IIa fibers, and 14.3% type IIx muscle fibers were used by assessing muscle damage and measuring 
dystrophin staining.  It was concluded that type II muscle fibers perform the majority of the work during 
eccentric exercise and, therefore, experience the most damage. 
MEASURING THE EFFECTS OF DOMS 
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Using a visual analog scale (VAS) to determine changes in perceived pain has been shown to be 
an effective way in evaluating the success or failure of an exercise protocol (Jouris, McDaniel, & Weiss, 
2011; Corder, Newsham, McDaniel, Ezekiel, & Weiss, 2016; Nosaka & Newton, (2002); Mike, Cole, 
Herrera, VanDusseldorp, Kravitz, & Kerksick, 2017; Gulick, Kimura, Sitler, Paolone, & Kelly IV, 1996).  
Using a VAS to measure perceived soreness has been validated as a reliable method in previous research 
(Gallagher, Bijur, Latimer, and Silver, 2002).  The most common method of using a VAS involves using 
a ten-centimeter line on a piece of paper with zero (no pain) on the left and ten (very painful) on the right 
side of the line.  The participant places a mark on the line where they perceive their pain to be.  A ruler is 
then used to measure the distance in centimeters from the left side of the line to the mark placed by the 
participant. 
FATTY ACID SUPPLEMENTATION AND DOMS 
In recent years, more research has been conducted investigating the possible anti-inflammatory 
benefits of O3FA supplementation on athletic performance in untrained, recreationally trained, and 
collegiate athletes.  The most common forms of O3FA are eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA), which produces alpha linolenic acid (ALA) to produce anti-inflammatory 
cytokines.  O3FA are found in fatty fishes (salmon and tuna), walnuts, and chia seeds (Pickova, 2009; 
Baran, Kelly, Kress, Landgraf, & Weiss, 2015). 
There is some variation in the supplementation protocol in the research, ranging from acute 
supplementation (approximately one week) to more long-term chronic supplementation (approximately a 
month or longer).  Studies following acute supplementation protocol prescribe 3,000 mg of EPA and 
DHA per day, which is the United States Food and Drug Administration’s safe limit for O3FA daily 
intake (Food and Drug Administration, 2004).  The United States FDA does not specify values for EPA 
or DHA for acute or chronic supplementation.  In research, dosages for chronic supplementation range 
from 1.8 grams to 2.4 grams per day (Tsuchiya, Yanagimoto, Nakazato, Hayamizu, & Ochi, 2016; Rajabi, 
Lofti, Abdolmaleki, & Rashid-Amiri, 2013; Gray, Chappell, Jenkinson, Thies, & Gray, 2014; Tartibian, 
Maleki, & Abbasi, 2009; Lenn et al., 2002; DiLorenzo, Drager, & Rankin, 2014). 
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In 2009, Tartibian, Maleki, and Abbasi (2009) evaluated the effects of O3FA supplementation in 
27 untrained men (experimental group, n = 9; placebo, n = 9, control, n = 9; 33.4 ± 4.2 years) for 
perceived pain and ROM following 30 days of omega-3 supplementation.  Participants consumed 1.8 
grams of O3FA per day prior to the start of exercise and 48 hours following exercise.  The O3FA group 
also took 100 IU of d-alpha-tocopherol/d-alpha-tocopherol acetate to minimize long chain fatty acid 
oxidation during the study.  Participants performed 40 minutes of eccentric exercise consisting of bench 
stepping for five minutes with one minute of rest between stepping periods at a pace of 15 steps per 
minute.  There was no significant difference (p > 0.05) for perceived soreness between the control and 
O3FA groups immediately after exercise or 24 hours later.  48 hours after exercise, perceived pain was 
significantly greater (p < 0.001) in the control group, experiencing more pain.  The same result was seen 
in ROM 48 hours following exercise with the control group having a decreased ROM when compared to 
the O3FA group (p = 0.031).  Results from this study concluded that ingestion of 1.8 grams of O3FA per 
day can alleviate the effects of DOMS induced by eccentric exercise. 
Lenn et al. (2002) used a similar supplementation protocol as the previous mentioned study 
(Tartibian, Maleki, and Abbasi, 2009) but did not report any anti-inflammatory benefits from O3FA 
supplementation.  Ten men (22.7 ± 3.92 years) and six women (24.5 ± 5.47 years) completed the study. 
Participants were divided into three groups: fish oil group (n=7) receiving 1.8 grams of O3FA and wheat 
flour, isoflavone group (n=8) receiving 120 mg of soy isolate and Western fat blend, and placebo group 
(n=7) receiving comparable amounts of Western fat blend or wheat flour compared to the other two 
groups.  All groups followed supplementation protocol for 30 days prior to exercise and during the week 
of the exercise protocol.  All groups received 100 IU of d-alpha-tocopherol/d-alpha-tocopherol acetate to 
minimize long chain fatty acid oxidation.  Following supplementation protocol, participants performed 50 
maximal effort eccentric bicep curl contractions using a KinCom Dynamometer.  Participants returned on 
days 2, 4, and 7 following exercise to determine measures for soreness and ROM.  Soreness and ROM 
were significantly changed (p < 0.05) from day zero to day two in all groups but there was no significance 
observed between groups in that time period.  Unlike the findings of Tartibian, Maleki, and Abbasi 
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(2009), there was not an indication that O3FA supplementation could help reduce the symptoms of 
DOMS. 
Gray, Chappell, Jenkinson, Thies, and Gray (2014) showed six weeks of 3,000 mg of fish oil 
supplementation reduced markers of oxidative stress but did not alleviate perceived muscle soreness 
resulting from eccentric exercise.  20 recreationally active males (23 ± 2.3 years) were divided into two 
groups: placebo (n=10) and fish oil (n=10).  The placebo group took 3 grams of olive oil while the fish oil 
group took 3 grams of fish oil per day for six weeks prior to an exercise protocol consisting of 200 
eccentric knee contractions.  Perceived muscle soreness increased significantly (p < 0.05) in both groups 
48 hours following exercise indicating that the exercise protocol effectively elicited a response, however, 
there was no difference between groups (p > 0.05).  Creatine kinase levels significantly increased (p< 
0.05) in both groups 48 hours following exercise with no interaction seen observed between the groups (p 
> 0.05).  Thiobarbituric acid reactive substances (TBARS) serum levels, a byproduct of lipid 
peroxidation, was significantly lower (p<0.05) in the fish oil group at 48 hours than the control group.  A 
limitation of the study was although fish intake was monitored every week during the study, a full 
nutritional evaluation was not made.  This could raise the possibility that caloric and other nutrient intake 
may play a role in the efficacy of O3FA supplementation to alleviate the effects of DOMS. 
Santos et al. (2012) monitored seventeen male participants in the military (18.6 ± 0.5 years) who 
were placed into one of two groups: placebo (n=9) or supplement group (n=8) for four weeks.  The 
supplement group received 1,000mg of O3FA and the placebo group received a 700 mg of a gel with no 
caloric value, three times per day.  The placebo group received a similar capsule as the supplement group 
that contained 80 mg of maltodextrin three times per day.  Creatine kinase and C-reactive protein were 
measured before supplementation, following three days of no physical activity, the night before the start 
of boot camp, and on the third night of boot camp.  The boot camp regimen consisted of five days 
controlled, caloric restriction with each participant receiving 3,000 to 3,600 calories per day.  On the 
fourth day of boot camp, participants began military survival training.  Only on the third day were 
participants permitted to sleep for exactly two hours.  Creatine kinase levels were lower in the supplement 
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group on the third day of boot camp, but it was not significant when compared to the placebo group.  C-
reactive protein serum levels were significantly lower (p < 0.05) in the supplement group on the third 
night of boot camp compared to the placebo group.  It was concluded that despite caloric deprivation 
common with boot camp, O3FA supplementation for three weeks was still effective in attenuating 
inflammatory activity in these participants. 
In 2016, Tsuchiya, Yanagimoto, Nakazato, Hayamizu, & Ochi evaluated the effects of eight 
weeks of O3FA supplementation on maximal voluntary contractions (MVC) and ROM.  Twenty-four 
healthy men (19.5 ± 0.8 years) were placed into either a placebo group (n=12), which received 2,400 mg 
of corn oil per day or the supplement group (n=12), which received 2,400 mg of omega-3 supplement.  
Perceived muscle soreness was evaluated using a VAS, and ROM was measured using a goniometer to 
determine differences in elbow extension.  Using a Biodex Multi-Joint System 3, participants completed 
five sets of six repetitions of elbow flexors.  The participants were told to resist the movement of the 
isokinetic arm, moving at 30° per second, for three seconds per repetition.  Participants were evaluated 
two, three, and five days following eccentric exercise.  MVC was significantly higher (p < 0.05) in the 
supplement group than the control group on days two, three, and five.  Elbow ROM was significantly 
higher (p < 0.05) in the supplement group when compared to the control group at days two, three, and 
five.  Perceived muscle soreness was shown to be significantly higher (p < 0.05) in the control group 
three days following exercise, however there was no significant change in soreness from baseline 
measures to any re-testing point in either group.  The study concluded that O3FA supplementation can 
attenuate the effects of DOMS when measuring strength and ROM. 
Recent research has shown acute supplementation lasting approximately seven to ten days at 
3,000 mg per day has been effective at reducing the effects of DOMS (Atashak, Sharafi, Azarbayjani, 
Stannard, Goli, & Haghighli, 2013; Corder, Newsham, McDaniel, Ezekiel, & Weiss, 2016; Jouris, 
McDaniel, & Weiss, 2011). 
In a 2013 study, Atashak, Sharafi, Azarbayjani, Stannard, Goli, and Haghighli blood levels of 
oxidative stress, muscle damage, and markers of inflammation following seven days of 3,000 mg of 
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O3FA supplementation in twenty men were evaluated.  Participants were placed in either an O3FA group 
(n=10; 20.24 ± 1.87 years) or a placebo group (n=10; 21.55 ± 2.34 years).  The O3FA group received 
three pills of 1,000 mg of O3FA to be consumed at three meals throughout the day for seven days.  The 
placebo group received a supplement visually similar to the O3FA group at the same times.  Participants 
performed four sets of 10 repetitions with three minutes of rest for 120% of their 1RM for the leg press, 
leg extension, and leg curl exercises.  Blood samples were collected one week prior to supplementation, 
immediately before exercise, and 24 hours following exercise protocol.  24 hours following exercise, C-
reactive protein and creatine kinase serum levels were significantly lower (p < 0.001) in the placebo 
group but not the O3FA group.  Based on this study, it can be concluded that 3,000 mg of O3FA 
supplementation for seven days can reduce markers of inflammation following a single session of 
strenuous resistance exercise. 
In a study by Corder, Newsham, McDaniel, Ezekiel, and Weiss (2016), 27 women (33 ± 2 years) 
received 3,000 mg of DHA or a matching placebo pill containing corn or soy oil.  The purpose of the 
study was to investigate the effects of DHA supplementation on markers of inflammation in healthy 
women following eccentric exercise.  In order to elicit DOMS, participants completed 120% of their 
predetermined 1RM for 4 sets of eccentric bicep curls with their non-dominant arm until exhaustion with 
three minutes of rest between sets.  Sets ended when the participant could no longer lower the weight over 
four seconds for two consecutive repetitions.  Participants began taking supplements seven days prior to 
the exercise protocol and two days afterwards.  Leading up to testing, perceived muscle soreness and 
stiffness, and serum C-reactive protein levels were measured following the exercise protocol.  Palpated 
soreness, full extension soreness, and passive elbow soreness levels were all significantly increased (p < 
0.05) from baseline testing to the 48-hour follow-up within groups. C-reactive protein serum levels were 
not significantly different in the DHA group (p=0.55) or the placebo group (p=0.46).  Between groups, 
palpated soreness and ROM were significantly different 48 hours following exercise protocol with the 
placebo group being significantly higher (p < 0.05) compared to the O3FA group.  It was suggested that a 
lack of an increase in C-reactive protein levels did not increase because single-arm eccentric bicep curls 
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do not produce an adequate inflammatory response.  A limitation of the study is that it only looks at DHA 
supplementation and not a combination of EPA and DHA.  It was concluded that acute supplementation 
of 3,000 mg of DHA may be beneficial for healthy women to minimize the effects of DOMS following 
eccentric exercise. 
Using a similar supplementation and exercise protocol as the previous study, Jouris, McDaniel, 
and Weiss (2011) tested perceived muscle soreness in three men (37.0 ± 9.6 years) and eight women (34.1 
± 11.2 years) following 7 days of O3FA supplementation. All 11 participants completed both the control 
protocol and the O3FA protocol.  Participants were asked to refrain from eating foods that contained 
O3FA for the duration of the study.  During the O3FA protocol, participants were given five capsules 
totaling 3,000 mg per day of omega-3 supplement.  120% of their 1RM for eccentric bicep curls were 
performed for two sets to exhaustion.  The set ended when the participant was unable to lower the weight 
for four seconds for two consecutive repetitions.  Soreness significantly increased (p < 0.001) within all 
trials from the baseline measurement to 48 hours following the exercise protocol.  Between the control 
and O3FA trials, weighted soreness (p=0.02) and fully extended soreness (p=0.004) were both 
significantly higher in the control trial than in the O3FA trial. Based on the findings of this study, it was 
concluded that the exercise protocol was adequate enough to elicit an inflammatory response and the 
supplementation protocol of 3,000 mg of O3FA for seven days is adequate in alleviating the effects of 
DOMS.  
MECHANISMS OF O3FA 
When the inflammatory response in the body is activated, inflammation must be resolved in order 
for the inflamed site to return to homeostasis and to prevent inflammation from spreading or becoming 
chronic (Serhan, Chiang, & Van Dyke, 2008).  In order to return to homeostasis, leukocytes and debris 
must be removed from the affected area, which until recently, was considered to be a passive process but 
is now considered an active metabolic process (Serhan, Chiang, & Van Dyke, 2008).  Passive processes in 
the body do not require energy; however, returning to homeostasis is an active process. Returning to 
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homeostasis following an inflammatory response involves rapidly initiating responses by cellular 
pathways to synthesize dual-acting anti-inflammatory and pro-resolution lipid mediators. 
The first step to return to homeostasis in the body begins with the secretion of prostaglandins and 
leukotrienes which become active and begin to increase at the beginning signs of inflammation (Serhan, 
Chiang, & Van Dyke, 2008).  Prostaglandin E2 and prostaglandin D2 activate enzymes to produce 
lipoxins, resolvins, and protectins.  These pro-resolution molecules serve to promote homeostasis in the 
body by playing a role in stopping the entry of neutrophils into the inflamed areas, stimulate monocyte 
recruitment, and stimulate phagocytosis of microorganisms and apoptotic cells (Serhan, Chiang, & Van 
Dyke, 2008). 
Lipid mediators, such as prostaglandins and leukotrienes, are secreted during an inflammatory 
response and compete with arachidonic acid (ADA) for eicosanoid generation.  As inflammation 
continues, leukotriene B4 production is ceased by neutrophils and instead begin to convert ADA to 
lipoxins.  Lipoxins, specifically lipoxin A4 and lipoxin B4 serve as agonists to end inflammation and 
return the body to homeostasis by preventing neutrophils from entering inflamed sites (Serhan, Chiang, & 
Van Dyke, 2008).  Lipoxin interaction with other cells does not stimulate further Ca2+ influx which is a 
known reason for the start of an inflammatory response (Serhan, Chiang, & Van Dyke, 2008).  Lipoxin 
A4 also plays a role in reducing pain during inflammation by preventing organ fibrosis and acting on 
smooth muscle (Serhan, Chiang, & Van Dyke, 2008). 
Aspirin inhibits prostaglandin biosynthesis and stimulates the creation of aspirin-triggered 
lipoxins (ATLs) (Serhan, Chiang, & Van Dyke, 2008).  ATLs protect tissue during inflammation and play 
an important role in endogenous anti-inflammatory systems by stimulating haeme oxygenase (HO1).  As 
seen in mice, aspirin stimulates lipoxins to produce nitric oxide preventing leukocytes from attaching 
themselves to endothelial cells.  Furthermore, lipoxins and ATLs act on human T cells to block TNF-
alpha, preventing the stimulation of an inflammatory response (Serhan, Chiang, & Van Dyke, 2008).  
Resolvins are derived from EPA and DHA and are classified as E-series and D-series resolvins.  
Resolvin E1 prevents neutrophils from traveling across the endothelium to the site of inflammation 
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(Serhan, Chiang, & Van Dyke, 2008).  Resolvin E2 also displays anti-inflammatory characteristics by 
preventing zymosan-initiated neutrophil infiltration (Serhan, Chiang, & Van Dyke, 2008).  EPA-derived 
resolvins may be responsible for the anti-inflammatory characteristics attributed to O3FA demonstrating 
that 5-lipoxygenase in human leukocytes may signal the production of leukotrienes to inhibit an 
inflammatory response.  DHA-derived resolvins, 17S and 17R D-series display anti-inflammatory 
characteristics particularly in the DHA-rich areas of the body like the brain, synapses, and retinas (Serhan, 
Chiang, & Van Dyke, 2008).  Both 17S and 17D have been shown to block TNF-inducing transcripts for 
interleukin-1ꞵ which is expressed primarily during a neuronal injury (Serhan, Chiang, & Van Dyke, 
2008).  
DHA is converted from resolvins to protectins via lipoxygenase pathways to a 17S-
hydroperoxide-containing intermediate (Serhan, Chiang, & Van Dyke, 2008).  The 17S-hydroperoxide-
containing intermediate is then converted to a 16(17)-epoxide by leukocytes which is then opened in these 
cells to protectin D1.  Protecting D1 plays a role in inflammation by reducing TNF-alpha secretion and 
promoting T-cell apoptosis (Serhan, Chiang, & Van Dyke, 2008).   
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CHAPTER 3 
METHODS 
The purpose of this study was to investigate the effects of acute O3FA supplementation on 
perceived muscle soreness, ratings of exertion, and recovery after a lower body resistance training 
protocol in college-aged males. 
PARTICIPANTS 
Twenty-one college aged males from a southeast university that were untrained in resistance 
training were recruited for the study.  Inclusion criteria consisted of being 18-24 years old and engaging 
in less than one organized resistance training session per week for the previous six months.  Participants 
were excluded if they consumed O3FA supplements in the previous six months, had a lower limb injury 
in the previous six months, had a history of hypertension, malignancy, diabetes, clotting disorders, or 
were currently taking non-steroidal anti-inflammatory drugs (NSAIDs) or anti-coagulants.  Subjects were 
asked to refrain from taking NSAIDs for the duration of the study.  Participants were also excluded if they 
ate a diet high in O3FAs, defined as more than two times the adequate intake (1.6 grams per day) for adult 
males (Williams, Rawson, & Branch, 2017), one week prior to the start of the study or had a fish or 
seafood allergy.  Participants were asked to refrain from participating in resistance training for the 
duration of the study.  Participants were given a thorough explanation on the resistance training protocol 
and the nutrition supplementation protocol.  The participants were informed of possible benefits and risks 
from the training protocol as well as the nutrition supplementation protocol for this study. In addition, all 
participants were asked to complete and sign a written informed consent, a written health history 
questionnaire, and a written food allergy questionnaire prior to beginning the study. This study was be 
approved by the Institutional Review Board (IRB) at Georgia Southern University prior to beginning 
recruitment.  
INSTRUMENTATION  
Participant’s height and weight were assessed in the Human Performance Laboratory at a 
southeast university during the first week of the study.  Body weight (kilograms) was measured using a 
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Siltec® digital scale and height (centimeters) was measured using a stadiometer and recorded to the 
nearest 0.1 centimeter.  Participants were instructed to stand with their back against the stadiometer, with 
the scapulae and buttocks in contact with the wall (if possible), and weight evenly distributed between 
both feet.  The participants were instructed to stand erect and look straight ahead. 
Participants were asked to use a visual analog scale (VAS) to determine a baseline measure for 
perceived muscle soreness at the start of pre-testing and at the end of post-testing.  For VAS, participants 
placed a mark on a ten-centimeter (100 millimeter) line with the distance measured from the left end of 
the line (zero, no pain) to the right end of the line (100, in extreme pain) using a ruler to determine the 
score in millimeters (mm). The VAS scale has been validated as a subjective measure for soreness 
(Gallagher, Bijur, Latimer, and Silver, 2002). 
Prior to beginning the exercise protocol, participants were asked to rate perceived recovery using 
a perceived recovery status (PRS) scale.  The PRS scale represents varying levels of an individual’s 
perceived recovery using a zero (very poorly recovered) to ten (very well recovered) scale (Laurent et al., 
2011).   
Following each testing session, participants were asked to rate perceived exertion for that 
particular training session using an OMNI Session Rating of Perceived Exertion (RPE) scale.  The Omni 
Session RPE is a scale representing varying levels of an individual’s perceived exertion using a zero 
(extremely easy) to ten (extremely difficult) scale (Robertson et al., 2003). 
PROCEDURES  
Participants completed the leg press exercise, followed by the leg extension exercise, and then the 
lying leg curl exercise.  The leg press exercise was performed using a Cybex Leg press machine (Lumex 
Inc, Ronkonkoma, NY, model no. 5320).  The seated leg extension and lying leg curl exercises were 
performed using an Optima Series Leg Extension/Curl machine (Life Fitness, Rosemont, IL, model no. 
OSLEC-0102-203).  Exercise technique protocol has been outlined by Haff and Triplett (2016).  
LEG PRESS 
Starting Position: 
28 
 
 Sit in the machine with the lower back, hips, and buttocks pressed against the seat.  Place the feet 
on the platform shoulder-width apart with the toes slightly pointed out and legs parallel to each other.  
Grasping the handles on the side of the machine, move the hips and fully extend the knees without 
forcefully locking the knees.  Keeping the hips on the seat and back firmly pressed against the back pad, 
remove the support mechanism from the foot platform and grasp the handles on the seat.   
Downward Movement Phase: 
 Slowly flex the knees and hips to lower the platform towards the body.  Keep the buttocks and 
back firmly pressed against the pad.  Keeping the knees aligned over the feet as they flex, allow the hips 
and knees to flex until the thighs are parallel to the platform.  Do not allow the buttocks or hips to lose 
contact with the pads or the heels to rise off of the platform. 
Upward Movement Phase: 
 Extend the hips and knees pushing the platform away from the body without forcefully extending 
the knees.  Keeping the back and buttocks in contact with the pads, do not allow the buttocks to rise and 
keep the knees over the feet as they extend.  At the end of each set, return the support mechanism to the 
starting position, remove the feet, and exit the machine. 
LEG EXTENSION 
Starting Position: 
Sit down on the machine with the back firmly pressed against the back pad.  Place feet behind 
and in contact with the roller pad in contact with the ankles. Legs should be parallel to each other.  Align 
the knees with the edge of the seat.  Adjust the back pad or roller pad if necessary.  Grasp the handles 
located on the sides of the seat. 
Upward Movement Phase: 
Raise the roller pad by fully extending the knees keeping the back erect and firmly in contact with the 
pad.  Keep the thighs, lower legs, and feet parallel to each other.  Maintain a tight grip on the handles.  Do 
not forcefully lock out the knees. 
Downward Movement Phase: 
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Allow the knees to slowly flex back to the starting position for a count of three seconds to ensure the 
weight is controlled during the eccentric phase in order to reduce the risk of injury.  The technician will 
verbally count down for each repetition.  Keep the torso erect and back firmly pressed against the back 
pad.  Keep the thighs, lower legs, and feet parallel to each other.  Do not allow the buttocks to lift off of 
the seat by maintaining a firm grip on the handles. 
LYING LEG CURL 
Starting Position: 
Lie down on the machine with the front of the torso firmly pressed on the back pad.  Place the feet 
underneath and in contact with the roller pad in contact with the ankles.  Legs should be parallel to each 
other.  Align the knees with the edge of the seat.  Adjust the back pad or roller pad if necessary.  Grasp 
the handles located on the front of the pad. 
Downward Movement Phase: 
Curl the roller pad towards the buttocks by fully flexing the knees.  Keep the torso stationary with the 
hips and torso firmly pressed against the pads.  Do not allow the hips or torso to lift off of the pads by 
maintaining a tight grip on the handles located on the front of the seat. 
Upward Movement Phase: 
Allow the knees to slowly extend back to the starting position for a count of three seconds to ensure 
the weight is controlled during the eccentric phase in order to reduce the risk of injury.  The technician 
will verbally count down for each repetition.  Keep the torso stationary and the hips and torso firmly 
pressed against the pads by maintaining a tight grip on the handles.  Do not forcefully lock out the knees. 
Determination of 10-Repetition Maximum: The ten-repetition maximum (10RM) protocol has 
been established as valid and reliable (McLester et al., 2003) and was used in this testing.  On the same 
day as the informational meeting, participants reported to the weight room facility to determine a 10RM 
for the leg press, seated leg extension, and lying leg curl exercises.  Using a protocol similar to Ryan, 
Long, Bishop, Herron, and Katica (2013), an estimate weight for the starting load of the 10RM testing 
was needed for all exercises.  To determine this weight, participants performed a warm-up set at a weight 
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easily allowing for 15 repetitions, then were asked to estimate what weight that could be lifted for 10 
repetitions to reach fatigue on the final repetition.  The process was repeated, either raising or lowering 
the weight by five or ten pounds until the participant reached fatigue on their tenth repetition.  10RM was 
determined within three sets, and participants were given four minutes of rest between sets to ensure 
sufficient recovery before starting the next set.  Once a 10RM weight was established for all exercises, it 
was recorded and used for all post-training sessions.  To ensure proper technique, the same technician 
supervised all 10RM tests.  Rest time will be kept using a DICK’S Sporting Goods Stopwatch (Dick’s 
Sporting Goods, Coraopolis, PA).  
Exercise Protocol:  Participants reported to the testing facility at the same time of day for 
induction of DOMS and 24 hours later for re test.  The testing protocol for the current study is similar to 
the protocol in a study by Ryan, Long, Bishop, Herron, and Katica (2013).  Prior to the exercise protocol, 
participants were asked to determine perceived muscle recovery using the PRS scale.  A 100-millimeter 
visual analog scale was used to determine perceived muscle soreness.  Using 60% of the participants pre-
determined 10RM for the leg press, leg extension and lying leg curl exercises, one, ten repetition warm-
up set were performed.  All exercises were performed in a pattern of three sets of 75% of a one repetition 
maximum, until fatigue, with four minutes of rest between sets.  Participants were instructed to continue 
each exercise until fatigue was achieved during each set.  Verbal encouragement was not be given to 
participants.  The technician verbally counted the overall repetitions for the set, and count to three during 
the eccentric phase of the lift.  Following the completion of each set, the total number of repetitions 
completed were recorded for that set by the technician.  This procedure was repeated for all sets, all three 
exercises, during all exercise protocols.  
Fifteen minutes after the completion of both lifts during the exercise protocol, participants were 
asked to rate the overall workout difficulty using the OMNI Session RPE and complete a post-exercise 
VAS for perceived muscle soreness.  Participants were sent home and instructed to return 24 hours after 
the first trial to complete the second exercise protocol.  They were asked to estimate muscle recovery 
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using the PRS scale and complete a pre-exercise VAS for perceived soreness.  After these are recorded, 
participants underwent the same exercise protocol as the first testing session.   
Following the completion of the second exercise protocol, participants began a one-week (seven 
days) washout period.  The exercise protocol, in its entirety, was repeated following the washout period 
and the second supplementation period. 
Supplementation Protocol:  On the same day as determining 10RM, participants received the 
first round of supplements by an independent party and began the first supplementation period the 
following day.  Participants were randomly placed in either the experimental group or placebo group.  
Using a cross-over protocol, participants were given 35 O3FA capsules (Rx Omega-3 Factors, Natural 
Factors, Everett, Washington; 600 mg O3FA per soft gel capsule; 400 mg EPA, 200 mg DHA) or 35 olive 
leaf extract capsules (Olive Leaf Extract, Spring Valley Herbs and Natural Foods, Springfield, MO; 
150mg). Participants were instructed to take five capsules over three meals throughout the day totaling 
3,000 mg O3FA (2,000 mg EPA, 1,000 mg DHA) per day, taking no more than two capsules per meal.  
To monitor adherence to the protocol, participants were given a sheet to fill out the times they took their 
supplements every day throughout the supplementation periods and were asked to turn these sheets in at 
the end of each supplement period.  
Nutrition Intervention:  Participants were asked to limit the amount of OMFA in the diet during 
the study. To help ensure compliance, all participants were provided with a list of food sources that were 
moderate to high in O3FAs and were asked to refrain from eating these foods for the duration of the 
study.  The purpose of asking participants to refrain from moderate-to high O3FA food sources was to 
control for any variance in O3FA intake that may come from their diet.  Participants were asked to keep a 
three-day food record journal during the supplementation periods covering the day before the first 
exercise protocol, the day of the first exercise protocol, and the day of the second exercise protocol and 
replicate their diet on the day prior to the third exercise protocol, the day of the third exercise protocol, 
and the day of the fourth exercise protocol. This was to prevent large variations in caloric and 
macronutrient intake that may alter the outcome of the tests.  Food journals were evaluated using the 
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United States Department of Agriculture SuperTracker (United States Department of Agriculture, 
Alexandra, VA). 
STUDY TIMELINE 
Days 1: Details regarding the procedures of this study were provided to all participants, including 
the exercise and supplement protocols and study timeline.  Participants were asked to sign an informed 
consent form, and complete a health history questionnaire and a food allergy questionnaire.  
Anthropometric measures (height and weight) and demographic data (age) were collected from all 
participants.  Next, participants were introduced to the OMNI Session RPE, Perceived Recovery Scale 
(PRS), and a 10 centimeter visual analog scale to determine perceived muscle soreness.  They were 
informed of the proper technique for the three exercises: (1) Leg press (2) Seated knee extension (leg 
extension) (3) lying knee flexion (leg curl).  After proper technique was discussed, each participant had 
their 10RM determined for the leg press, leg extension and lying leg curl exercises.  Lastly, participants 
were randomly given either the experimental or placebo supplement and were asked to begin taking the 
assigned supplement the next day.   
Days 2-8:  Participants consumed no more than two experimental or placebo capsules at every 
meal totaling five capsules (3,000 mg O3FA or 150 mg olive oil extract) per day. 
Days 9-10:  Following seven days of the first supplementation period, participants reported to the 
weight room facility for the first exercise training session.  Twenty-four hours following the first exercise 
training session, participants reported back to the weight room facility for the second exercise training 
session.     
Days 9-15:  Participants did not receive any supplements during the seven day “washout period”.  
Participants were asked to continue to follow the O3FA restrictive diet and refrain from resistance 
exercise during the 7-day washout period.  On the last day of the washout period, participants received the 
other supplements for the group they were not in during the first supplementation period to start the next 
day. 
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Days 16-22: Participants consumed no more than two experimental or placebo capsules of the 
different supplement at every meal totaling five capsules (3,000 mg O3FA or 150 mg olive oil extract) per 
day.  Groups receiving the placebo in the first supplementation period received the experimental 
supplement in the second supplementation period.  Participants receiving the experimental supplement in 
the first supplementation period received the placebo supplement in the second supplementation period. 
Day 23-24:  Following the second supplementation period, participants reported back to the 
weight room facility for the third exercise session. Twenty-four hours following the third testing session, 
participants reported back to the weight room facility for the fourth exercise training session. 
STATISTICAL ANALYSIS 
Before any statistics are run, all data was tested for normal distribution.  In the event of a 
violation in normative data, a nonparametric test of the null hypothesis, Wilcoxon Signed-rank Test, was 
conducted.  Descriptive statistics (means, frequencies) on all demographic variables were calculated.  A 
paired-sample t-test was conducted between the placebo and O3FA supplementation protocol for 
perceived muscle soreness, total number of combined repetitions completed, difference of number of 
repetitions from both test sessions, subjective ratings of exertion, and perceived recovery.  Significance 
was set at p ≤ 0.05.  All statistical analyses will be calculated in SPSS v. 23 (IBM Inc, Armonk, NY). 
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CHAPTER 4 
RESULTS 
Participant Characteristics 
14 enrolled in the study and four dropped out during the first supplementation period, one for personal 
reasons, two due to unforeseen scheduling conflicts, and one due to injury sustained outside of the study.  
A total of 10 of the 14 college-age males completed the study.  The mean ± standard deviation age for all 
participants (n = 10) are shown in Table 1. 
Muscle Soreness 
No significant difference was observed in the change in perceived muscle soreness after 24 hours between 
conditions (Control: 16.6 ± 27.4; O3FA: 19.7 ± 17.4; p=0.72).  Results for Change in 24 Hour Perceived 
Soreness between Conditions are shown in Table 2.  There was no significant difference in perceived 
soreness 24 hours after induction of DOMS between conditions (Control: 33.7 ± 17.6; O3FA: 26.8 ± 21.0; 
p=0.47).   
Difference in Number of Repetitions 
There was a significant difference in total number of repetitions between the first and second trials in the 
placebo group (p = 0.01) resulting in a decrease of 15% in the total number of repetitions from testing 
session one and testing session two.  In the O3FA group, there was no significant difference between trial 
one and trial two in total number or repetitions (p = 0.16).  There was no significant difference in the 
change in total repetitions completed between trial one and trial two for the placebo and O3FA groups 
(p=0.19).  Difference in number of repetitions is shown in Table 4, and difference in number of 
repetitions between conditions is shown in Table 5. 
Rating of Perceived Exertion 
No significant difference was observed in perceived exertion between placebo testing session 2, Mdn = 7, 
and O3FA testing session 2, Mdn = 6, Z = 7, p = 0.88.  Perceived exertion between conditions is shown in 
Table 6. 
Perceived Recovery 
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O3FA perceived recovery scores, Mdn = 4.0, were not statistically higher than the control median placebo 
scores, Mdn = 6.0, Z = 25.5, p = 0.38.  Perceived recovery results are shown in Table 7. 
Nutrient Intake 
There was no significant difference in total energy intake (Placebo: 5,547.7 ± 1,705.2 kcal; O3FA: 
4,972.1 ± 1,709.8 kcal; p = 0.25) between groups.  There was so statistical difference in fat intake 
(Placebo: 235.5 ± 81.4; O3FA: 215 ± 87.7; p = 0.08) between groups.  A Wilcoxon Signed-rank Test 
indicated that the median carbohydrate intake O3FA scores, Mdn = 518.0, were not significantly higher 
than the median placebo scores, Mdn = 587.0, Z = 17, p = 0.51.  There was no observed difference in 
median protein intake O3FA scores, Mdn = 237.5, and the median placebo scores, Mdn = 221, Z = 25.5, p 
= 0.83.  Nutrient analysis results are shown in Table 8. 
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CHAPTER 5 
DISCUSSION 
 The purpose of this study was to investigate the effects of acute O3FA supplementation 
on perceived muscle soreness, ratings of exertion, and recovery after a lower body resistance training 
protocol in college-aged males.  While there has been an increase in research investigating the effects of 
O3FA supplementation on DOMS in recent years, there is a large variation in supplementation protocol, 
the source of O3FA, and the method of inducing DOMS.   
This study suggests that acute supplementation of O3FA at 3,000 mg per day for seven days may 
inhibit the negative effects caused by resistance training 24 hours after the induction of DOMS by 
accelerating recovery, but supplementation did not improve perceived muscle soreness.  The primary 
findings of this study showed there was a significant decrease in the number of repetitions completed 
during the second exercise training session in the control group, but not the O3FA group.  This means that 
the O3FA group was objectively better recovered from the first exercise training session than the control 
group providing reason to believe acute O3FA supplementation may be effective in accelerating recovery.  
There was no significant difference in changes in perceived muscle soreness 24 hours following the 
induction of DOMS between the control and O3FA groups.  There was no significant difference between 
total repetitions completed during either exercise training session between conditions or in the difference 
in number of repetitions from training session one to training session two between the control and O3FA 
groups.  There was no difference in perceived recovery status at the beginning of training session two 
between supplement groups.  Perceived exertion was not significantly different between the control and 
O3FA groups. 
The majority of O3FA supplementation studies have determined decreased perceived muscle 
soreness as a primary benefit of O3FA supplementation (Tartibian, Maleki, & Abbasi, 2008; Lenn et al., 
2001; DiLorenzo, Drager, & Rankin, 2014; Gray, Chappell, Jenkinson, Thies, & Gray, 2014; Santos et 
al., 2012; Rajabi, Lotfi, Abdolmaleki, & Rashid-Amiri, 2013; Tsuchiya, Yanagimoto, Nakazato, 
Hayamizu, & Ochi, 2016; Atashak, Sharafi, Azarbayjani, Stannard, Goli, & Haghighli, 2013; Corder, 
37 
 
Newsham, McDaniel, Ezekiel, & Weiss, 2016; Jouris, McDaniel, & Weiss, 2011; Houghton & Onambele, 
2012; Baran, Kelly, Kress, Landgraf, & Weiss, 2015).  In each of these studies, DOMS was measured at 
multiple points, ranging from immediately following the induction of DOMS (Gray, Chappell, Jenkinson, 
Thies & Stuart, 2014; Tartibian, Maleki, Abbasi, 2009; Rajabi, Lofti, Abdolmaleki, & Rashid-Amini, 
2013; Tsuchiya, Yanagimoto, Nakazato, Hayamizu, & Ochi, 2016) to five days later (Tsuchiya, 
Yanagimoto, Nakazato, Hayamizu, & Ochi, 2016).  The current study observed significant increases in 
perceived muscle soreness from baseline on the first training session to the beginning of the second 
training session, 24 hours later, in both groups indicating the exercise protocol was effective in inducing 
DOMS.  To date, most research involving O3FA and DOMS has evaluated the effects of DOMS 48 hours 
post-exercise, as this is when the effects of DOMS peaks in the body.  Less research has been conducted 
evaluating DOMS 24 hours post-exercise.  
To date, one study has evaluated the effects of O3FA supplementation on DOMS over 24 hours 
post-exercise and saw a significant increase in perceived muscle soreness 24 hours after baseline 
measures (Rajabi, Lotfi, Abdolmaleki, & Rashid-Amiri, 2013).  The researchers observed a significant 
increase in perceived muscle soreness 24 hours following induction of DOMS as well as a significant 
difference between the experimental and control groups at this time point.  Much like the study conducted 
by Rajabi, Lotfi, Abdolmaleki, and Rashid-Amiri, the current study also observed a significant increase in 
perceived muscle soreness 24 hours from baseline testing.  This study also utilized an exercise protocol 
consisting of eccentric leg presses at a pre-determined %RM which is similar to the current study though 
only one exercise was used.  There was a difference in the volume of repetitions between the studies with 
Rajabi, Lotfi, Abdolmaleki, and Rashid-Amiri completing a set volume of four sets of 20 repetitions 
while the current study completed three sets until failure for three different exercises.  Nonetheless, both 
studies showed improvements in perceived muscle soreness following O3FA supplementation 24 hours 
following the induction of DOMS.   
In contrast, a study conducted by Gray, Chappell, Jenkinson, Thies, and Gray (2014) did not 
observe a significant increase in DOMS from baseline measures or a significant difference between 
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groups in DOMS 24 hours after baseline measures.  The researchers measured perceived muscle soreness 
at multiple points after the induction of DOMS and found no significant increase in DOMS at 24 hours 
post-exercise.  They concluded that O3FA supplementation ameliorated markers of oxidative stress, but 
not DOMS, following the exercise protocol.  It’s possible that the reason a significant increase in DOMS 
was not observed is due to the nature in which DOMS was induced in the study.  Different from the 
current study, resistance training exercises were not used to induce DOMS.  Though the volume of work 
was greater than the current study, because there was no resistance in the exercise protocol, there may 
have been insufficient muscle damage occurring to adequately induce DOMS.  A study conducted by 
Tsuchiya, Yanagimoto, Nakazato, Hayamizu, and Ochi (2016), used five sets of six eccentric bicep curls 
using a dynamometer to induce DOMS.  Participants were instructed to resist the dynamometer’s 
movement through the full range of motion for at least three seconds for each repetition.  Unlike the 
current study, the researchers also saw no significant difference in DOMS 24 hours post-exercise or any 
time point when compared to pre-test values in either group.  The O3FA group had significantly less 
perceived muscle soreness 72 hours following exercise than the placebo group, but there was no 
significant difference between groups until that time.  Unlike Gray, Chappell, Jenkinson, Thies, and Gray 
(2014), this study used a form of resistance training to induce DOMS, however, both studies completed a 
specific number of sets and repetitions instead of performing until complete muscle fatigue.  Both studies 
also utilized single-joint exercises while the current study which used both multi- and single-joint 
exercises which may have affected the effectiveness in inducing DOMS 24 hours after the first exercise 
training session.  Though previous studies have used resistance training protocols to induce DOMS, the 
study conducted by Tartibian, Maleki, and Abbasi (2008) used a bodyweight stepping protocol of eight 
sets for five minutes of stepping at a rhythm of 15 steps per minute totaling 600 steps.  The researchers 
measured DOMS before exercise, immediately after exercise, 24 hours, and 48 hours post-exercise.  At 
24 hours following exercise, DOMS was not significantly different between groups, but the experimental 
group’s perceived muscle soreness was significantly lower than the other groups at 48 hours.  Much like 
Gray, Chappell, Jenkinson, Thies, and Gray, the work volume was greater than the current study, and 
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though the step protocol was a multi-joint exercise, the fact that it did not involve resistance exercises 
may have played a role in the effectiveness of inducing DOMS during the study.  Differences in perceived 
muscle soreness from pre-exercise to 24 or 48 hours later was not evaluated to determine if the exercise 
protocol was effective in inducing DOMS.  By not measuring the change in perceived muscle soreness 
from pre-exercise to 24 or 48 after resistance training, it is difficult to determine if the protocol in this 
study was effective in inducing DOMS at all.  By comparing the methods used in the studies by Tsuchiya, 
Yanagimoto, Nakazato, Hayamizu, Ochi (2016) and Tartibian, Maleki, and Abbasi (2008), and Tartibian, 
Maleki, and Abbasi (2008) to the methods used in the studies described in the above paragraph, it can be 
suggested that multi-joint resistance exercises may be more effective at inducing DOMS 24 hours post-
exercise.   
 Although the current study found no significant difference in perceived recovery between the two 
different supplements, the control group recorded a higher score on the PRS scale than the O3FA group 
prior to starting the second exercise training session.  The median score for the control group was 
“adequately recovered”, noted as a six on the PRS scale, while the median O3FA group was reported to 
be “somewhat recovered”, noted as a four on the PRS scale.  Though these results were not statistically 
significant in this sample size, it is possible that the O3FA group’s median score might be considered 
practically significant during training meaning that O3FA supplementation may not be effective in 
accelerating recovery 24 hours following the induction of DOMS.  Korak, Green, and O’Neal (2015) 
observed the effects a high-volume resistance training protocol had on perceived recovery and concluded 
that a lower value on a PRS scale resulted in a greater change in performance. In contrast, the current 
study found an inverse relationship between the two. The control group, which felt more recovered than 
the O3FA group according to the PRS scale, completed significantly fewer repetitions during the second 
exercise training session when compared to the first exercise training session.  The current study found no 
significant difference between the control and O3FA groups in difference in number of repetitions 
completed during the first and second exercise training sessions between supplementation periods.  The 
O3FA group completed fewer repetitions during the second exercise training session when compared to 
40 
 
the first exercise training session, but not by a significant amount.  Although the O3FA group reported 
being less recovered according to the PRS scale, they were more recovered than the control group based 
on the number of repetitions they were able to complete during the second exercise training session.  This 
measure suggests that O3FA supplementation may be effective at inhibiting the negative effects of 
DOMS.  To date, the current study was one of the few studies measuring the effects of O3FA 
supplementation on perceived recovery following a resistance training program, and was the first study 
investigating the effects O3FA supplementation on the total number of completed repetitions and the 
difference in completed repetitions between exercise training sessions.  The mixed recovery results may 
be due to a lack of understanding on how the PRS scale worked.  This could have led to participants in 
one group picking a number that was not accurately indicative of their perceived recovery. 
No significant difference in RPE between the control and the O3FA group at any exercise 
training session was observed in the current study.  Between exercise training sessions one and two, the 
control group reported slightly higher ratings of perceived exertion than the O3FA group, though neither 
were significant in our sample size.  The results of the current study are similar with the results from 
Houghton and Onambele (2012), which concluded that O3FA supplementation had no effect on RPE 
following a resistance training protocol.  Like the current study, a combination of multi- and single-joint 
exercises were used to induce DOMS, but there was no difference in RPE between groups in either study.  
Korak, Green, and O’Neal (2015) investigated the effects of resistance training recovery using an RPE 
scale, which showed the O3FA group reported a lower RPE score at the beginning of the second testing 
session.  This study suggested that RPE was a useful predictor of performance and that a lower RPE 
rating was indicative of greater performance during testing.  Similar findings were also seen in the current 
study; all training sessions with a lower RPE were associated with completing more repetitions.  One of 
the inclusion criteria for the current study was that participants were to be untrained in resistance training, 
defined as averaging less than one organized resistance training session per week for the last six months.  
However, all of the participants were recruited from physical education classes from a southeastern 
university, so it is possible that some of the participants had higher fitness levels than the average 
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individual.  A study by Travlos and Maris (1996) evaluated the perceived exertion between individuals 
with high and low fitness levels and concluded that the perceived exertion was significantly greater in 
those with lower fitness levels when exercising at similar workloads.  Because there was not a significant 
difference in the number of repetitions completed at either testing day between both conditions in the 
current study, it can be suggested that these participants were engaging in similar relative workloads 
during the exercise training sessions.  
No significant differences in total energy, carbohydrate, fat, and protein intake were found 
between groups throughout the current study. The control group consumed more total calories, 
carbohydrates, and fat than the O3FA group, though not significantly more.  Despite none of these 
measures being significantly different than the O3FA group, there is no denying a higher carbohydrate 
intake may have influenced muscle glycogen synthesis and storage, potentially influencing the number of 
repetitions completed during testing sessions.  As exercise intensity increases, so does the utilization of 
carbohydrates as the primary source of fuel during anaerobic exercise, such as resistance training, while 
fat is the primary source of fuel during long-duration, aerobic exercise.  For this reason, it can be assumed 
that the difference in fat intake, which was approaching statistical significance, is less important than 
carbohydrate intake which was not significant.  The overall caloric intake of the control group was 
approximately 10% higher than the O3FA group though the bulk of these calories likely came from a 
difference in fat intake.  Of the studies compared to the current study, none utilized a food diary to 
monitor and compare macronutrient intake between groups to determine if a significant difference in may 
have affected performance during the exercise training sessions. 
Limitations 
Because of the time of year that recruitment began and the nature of the study involving 
participants experiencing muscle soreness multiple times throughout the study, a small sample size 
completed the study though the sample size was enough to provide adequate statistical power.  While 
most studies involving DOMS measure 48 hours following the induction of DOMS, this study measured 
at 24 hours potentially leading to a lack of significance between groups.  Water intake and hydration 
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status was not accurately monitored though participants were encouraged to drink at least two liters of 
water per day during testing.  It is difficult to ensure that participants kept honest food records during the 
study as a level of trust is assumed between the study conductor and participants.  It is also difficult to 
ensure participants measured accurate portion sizes during this period as most individuals are not well-
educated on how to estimate portion sizes as they received no training on how to estimate food portions or 
maintain a food journal at the beginning of the study.  However, based on the findings that there were no 
significant differences in nutrient intake, it appears the participant’s diets were consistent throughout the 
study.  Activity was not monitored or restricted during testing days.  Participants were recruited from 
physical education classes potentially causing a discrepancy in the amount of physical activity they were 
engaged in outside of the study.  The washout period length, though used in other studies involving O3FA 
supplementation and DOMS, may have been inadequate as some research has suggested washout periods 
ranging eight to sixteen weeks (Cao, Schwichtenberg, Hanson, & Tsai, 2006) may be more appropriate to 
allow erythrocyte membrane EPA and DHA levels to return to baseline measures following O3FA 
supplementation.  Due to the rate at which EPA and DHA are cleared from the erythrocyte membrane, 
DHA, which is cleared at a slower rate, was theorized by Cao, Schwichtenberg, Hanson, and Tsai to be 
the storage form of O3FA.  Despite remaining in the body longer than EPA, DiLorenzo, Drager, and 
Rankin, (2014) saw that DHA did not play a role in attenuating DOMS, but was helpful in attenuating 
other markers of inflammation.  However, Corder, Newsham, McDaniel, Ezekiel, and Weiss (2016) saw a 
significant decrease in DOMS in their study.  The difference between these two studies in the 
supplementation protocol may be the deciding difference as both received varying amount for different 
time periods.   
Conclusions 
To date, this is the first study to measure the total number of repetitions completed, the difference 
in repetitions completed between exercise training sessions, and perceived recovery status when 
supplementing with O3FA.  Although there were improvements in recovery between training sessions in 
the O3FA group, there was no difference in RPE, PRS, or perceived muscle soreness 24 hours after 
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exercise training sessions between groups, so it cannot be concluded that supplementing with O3FA will 
improve performance or ratings of recovery or ratings of exertion.  The study showed no significant 
difference in perceived muscle soreness, perceived exertion, or perceived recovery.  However, the control 
group completed significantly fewer repetitions on the second exercise training session while the O3FA 
group was closer to baseline numbers indicating they may have been more recovered during the second 
exercise training session.  The lack of significance in this study may be attributed to low sample size.   
Further studies should be conducted in which participants are asked to re-test 48 hours following 
the first training session, as some studies have shown a greater increase in perceived muscle soreness 48 
hours after induction of DOMS compared to 24 hours.  Studies should also utilize a washout period that 
allows for O3FAs to be adequately released form fat cells to allow O3FA levels to return to baseline 
measures before re-testing the sample size.  Participants should also be given adequate training on how to 
estimate portion sizes and record a food journal to help remove bias from the study.    Lastly, based on the 
results of this study and previous studies, future studies may be better served by focusing on large muscle, 
multi-joint, resistance exercises when inducing DOMS, particularly if the intention is to measure DOMS 
24 hours after exercise.  
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APPENDIX A 
Research Questions 
1. Will 3,000 mg of O3FA per day for seven days result in lower levels of perceived soreness and 
faster perceived recovery? 
Assumptions 
1. That all participants comply with the supplementation protocol. 
2. That all participants give maximal effort during training sessions. 
3. That all participants comply with the nutrition intervention. 
4. That all participants comply with the exercise protocol. 
5. That all participants will accurately document their food diaries. 
Limitations 
1. Only using untrained, college-aged (18-24) males. 
2. Time of school year limited recruitment possibilities. 
3. Cannot control diet or exercise outside of the lab setting. 
4. Compliance with placebo and O3FA supplementation 
5. Current research is conflicting on the efficacy of O3FA on attenuating DOMS. 
6. Time point at which DOMS was measured. 
7. Water intake and hydration status was not accurately monitored. 
8. Activity was not monitored during testing days. 
9. Participants had different levels of physical fitness at the start of the study. 
10. Washout period may not have been adequately long enough. 
11. Participants were not educated on how to properly measure accurate portion sizes for the food 
journal. 
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APPENDIX B 
 
WATERS COLLEGE OF HEALTH PROFESSIONS 
DEPARTMENT OF HEALTH SCIENCES AND KINESIOLOGY 
 
INFORMED CONSENT 
1. Principal Investigators:  
 Colin A Butler, Graduate student, Department of Health and Kinesiology, 678-362-3968 
Amy Jo Riggs, Ph.D., RD, LD Associate Professor, Department of Health and Kinesiology, 478-
7753 
2. Purpose of the Study: The purpose of this study is to investigate the effects of acute omega-3 
fatty acid supplementation on perceived muscle soreness, ratings of exertion, and recovery after a 
prescribed lower body resistance training protocol in college aged males.   
 
3. Procedures to be followed: You will be provided a list of foods moderate to high in omega-3 
fatty acid (O3FA) and be asked to refrain from consuming these foods for the duration of the 
study.  You will be provided a health history questionnaire (2017 PAR-Q) and an allergy 
questionnaire to sign and complete.  You will be asked to report to the Hanner Fieldhouse Human 
Performance Lab where your height and weight will be taken and recorded.  You will then report 
to the Hanner Fieldhouse weight facility to determine a ten-repetition maximum (10RM) for the 
leg press, leg extension, and lying leg curl exercises. Determining a 10RM consists of a warm up 
of each exercise at a weight that easily allows for 15 repetitions.  You will then estimate a weight 
you think you could complete to reach fatigue on the tenth repetition.  Weight will be raised or 
lowered by five to ten pounds reaching your 10RM by the third set.  Four minutes of rest between 
sets will be given to ensure recovery. Once this is completed, you will be randomly assigned to 
either the placebo or O3FA supplements the same day as 10RM testing to begin the following 
day.  You will take five capsules per day, no more than two per meal, for seven days.  You will 
then report after the supplementation period to the Hanner Fieldhouse weight facility to induce 
delayed-onset muscle soreness (DOMS). Prior to testing sessions, you will be asked to estimate 
your perceived recovery using a perceived recovery scale and perceived muscle soreness using a 
visual analog scale. You will complete three sets to fatigue using your 10RM for each exercise 
with four minutes of rest between sets. Fifteen minutes after testing is completed, you will 
estimate your perceived exertion using an Omni Session rating of perceived exertion scale and 
perceived soreness.  Twenty-four hours after induction of DOMS, you will report back to the 
Hanner Fieldhouse weight facility to repeat the testing process in its entirety.  You will then have 
a seven-day washout period. During the washout period, you will be asked to continue to follow 
nutrition intervention protocol and refrain from resistance training.  At the end of the washout 
period, you will receive the opposite supplement, following the same supplementation procedure 
as the first supplementation period completing the cross-over protocol. At the end of the second 
supplementation period, you will report to the Hanner Fieldhouse weight facility to induce 
DOMS a second time. Twenty-four hours after induction of DOMS, you will report back to the 
Hanner Fieldhouse weight facility to repeat the testing process in its entirety.  Prior to the first 
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testing session, you will be asked to keep a three-day food journal for the day before induction of 
DOMS as well as both testing days. You will be asked to replicate your diet from the first testing 
session for the second testing session.  All data will be archived for three years before being 
destroyed. 
 
4. Discomforts and Risks:  Risks associated with resistance training are minimal in healthy 
populations, but include muscle soreness, loss of range of motion, tenderness or stiffness in the 
affected limb, increase in limb circumference, and a decrease in muscle force production peaking 
48 hours following exercise, and typically disappears within 72 hours after appearing.  No 
research has shown the effects of DOMS to be permanent.  In extreme cases, injury such as 
muscle strains, or rhabdomyolysis (RML) are possible.  Primary factors resulting in RML include 
engagement in eccentric exercise by those with low exercise experience.  Secondary factors 
including electrolyte imbalance, low protein intake, excessive carbohydrate intake, and excessive 
exercise in high humidity and temperature have also been reported to increase the risk of RML.  
Extreme soreness and loss of range of motion in the affected limb may occur with this type of 
exercise, and it is possible that you may experience brown-colored urine.  You will be required to 
engage in a warm-up before exercise to reduce the chance of muscle damage and follow 
scheduled rest periods between exercises in accordance with the testing protocol.  The 
investigator will encourage you to stay properly hydrated by drinking at least 2 liters of water 
throughout the day, and that you bring water to each testing session as well as eat a recovery meal 
with 0.5g/kg of protein and 1.5g/kg carbohydrates following exercise to aid in recovery.  If you 
experience symptoms such as brown-colored urine, extreme muscle pain, or extreme loss in range 
of motion in the affected limbs, you will be encouraged to report to health services immediately 
and inform the investigator.  At that time, you will be removed from further participation.  The 
investigator will then inform the Georgia Southern University Institutional Review Board of the 
issue within 24 hours of its occurrence.  You understand that medical care is available in the 
event of injury resulting from research but that neither financial compensation nor free medical 
treatment is provided.  O3FA supplementation risks also include the possibility of belching, 
halitosis, heartburn, nausea, loose stools, rash, and nosebleeds.  Olive oil supplementation up to 
28 grams per day is well tolerated, but may lower blood sugar in diabetics and those who have 
recently had surgery.  Risks will be minimized through examination of medical health history 
forms to determine any health risks for fish allergies or resistance training testing. Although an 
allergic reaction to the fish oil supplements is not likely, you will be monitored closely to ensure 
you don’t have any adverse reaction from them. If you do begin to feel nauseous or lightheaded, 
or develop a rash, please communicate this immediately to one of the researchers.  
 
5. Benefits: O3FA supplementation may be effective in alleviating the effects of DOMS, which is 
beneficial for athletes.  Reducing the effects of DOMS and decreasing recovery time can help 
athletes train at a high level faster and improve competitive performance. O3FA supplementation 
research suggests that O3FA can reduce triglyceride levels and be effective in reducing the risk of 
heart disease. 
 
6. Duration/Time: Each session at the weight facility will take approximately 1 hour. This includes 
the warm up and the actual experimental trial. This leads to a total time commitment of five hours 
at the weight facility; one hour for determining a ten-repetition maximum, and one hour each for 
the following four testing periods. 
 
7. Statement of Confidentiality: All scientific and personal data collected on subjects for 
presentation purposes will be kept confidential and stored in a locked file drawer in Hollis 2121-
A. This information will be available only to the principal investigators. Your identity will not be 
revealed in publications or presentations that result from this study so as to protect your privacy 
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and confidentiality. All data will be reported as means and standard errors. Data will be kept for 3 
years and then destroyed.  Electronic data will be kept on a private hard drive and will be 
destroyed as soon as the data analysis has been run and the manuscript is complete. 
 
8. Right to Ask Questions: You have the right to ask questions and have those questions answered.  
If you have questions about this study, please contact Colin A Butler, graduate student, 
Department of Health and Kinesiology, 678-362-3968, cb05120@georgiasouthern.edu or Dr. 
Amy Jo Riggs, Ph.D., RD, LD Associate Professor, Department of Health and Kinesiology, 478-
7753, ajriggs@georgiasouthern.edu.  For questions concerning your rights as a research 
participant, contact Office of Research Compliance IRB@georgiasouthern.edu or call (912) 478-
5465. 
 
9. Compensation: All participants will be eligible for a one-time drawing to win a one-hundred-
dollar gift card at the end of the study.  Names will be placed into a bowl and an independent 
third party will draw one name from the bowl.  The name drawn will be contacted to retrieve their 
gift card. 
 
10. Voluntary Participation: Your participation in this study is entirely voluntary. If you decide to 
participate, you are free to withdraw your consent and to stop participating at any time without 
penalty or loss of benefits to which you are otherwise entitled. 
 
11. Penalty: If you decide not to participate, you will not be penalized, and you will not lose any 
benefits or services to which you are otherwise entitled. 
 
12. You must be 18 years of age or older to consent to participate in this research study.  If you 
consent to participate in this research study and to the terms above, please sign your name and 
indicate the date below.  
 
You will be given a copy of this consent form to keep for your records.  This project has been reviewed 
and approved by the GSU Institutional Review Board under tracking number H18212.  
Title of Project: The effects of acute omega-3 fatty acid supplementation on delayed-onset muscle 
soreness and recovery 
Principal Investigators:  
Colin A Butler, Graduate student, Department of Health and Kinesiology, 678-362-3968 
Amy Jo Riggs, Ph.D., RD, LD Associate Professor, Department of Health and Kinesiology, 478-7753 
 
______________________________________  _____________________ 
Participant Signature     Date 
 
I, the undersigned, verify that the above informed consent procedure has been followed. 
 
 
______________________________________  _____________________ 
Investigator Signature     Date 
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Food Allergy Questionnaire   
First Name: ____________________________  Last Name: _____________________________ 
  
Do you have a food allergy?   
 Yes (fill out form below, sign and return to study administrator)        No (initial bottom of page, 
return to study administrator)          
    
Please describe your food allergy or food intolerance.  
  
  
  
  
Was your food allergy diagnosed by a medical professional?   
  
   
  
  
Do you have medical documentation, such as a Medical Alert bracelet or necklace?   
  
  
  
  
Please describe what happens when you have a reaction.  
  
  
  
  
Is the information you provided accurate to the best of your ability? Please sign below and return the form 
to the study administrator.  
  
 
Signature: ___________________________________  Date: ____________________________  
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CAPSULE DIARY 
Day no. - Date Meal No. of Capsules Initial 
    
Day 1 
 
   
 
 
   
 
 
   
Day 2 
 
   
 
 
   
 
 
   
Day 3 
 
   
 
 
   
 
 
   
Day 4 
 
   
 
 
   
 
 
   
Day 5 
 
   
 
 
   
 
 
   
Day 6 
 
   
 
 
   
 
 
   
Day 7 
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FOODS HIGH IN OMEGA-3 FATTY ACIDS 
Source ALA (g) EPA + DHA (g) 
   
Flaxseed oil, 1 tbsp. 7.6 
 
 
Walnuts, 1 ounce 2.57 
 
 
Soybean oil, 1 tbsp. 0.92 
 
 
Beechnuts, 100g 1.7 
 
 
Butternuts, 100g 8.7 
 
 
Chia seeds, 1 ounce 5.06 
 
 
Anchovy, 100g  
 
1.449 
Herring, 3 ounces  
 
1.71 
Mackerel, 3 ounces  
 
1.02 
Salmon, 3 ounces  
 
1.83 
Sardine, 3 ounces  
 
1.19 
Trout, 3 ounces 
 
 0.884 
Tuna, canned, 3 ounces  0.19 
 
Tuna, steak, 3 ounces  0.10 
 
U.S. Department of Agriculture, Agricultural Research Service. USDA National Nutrient Database for 
Standard Reference, Release 28.  Nutrient Data Laboratory Home Page, 2015. 
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OMEGA-3 FATTY ACID SIDE EFFECTS AND USES 
O3FA Side effects 
Fish oil is LIKELY SAFE for most people when taken by mouth in low doses (3 grams or less per day). 
There are some safety concerns when fish oil is taken in high doses. Taking more than 3 grams per day 
might keep blood from clotting and can increase the chance of bleeding.  
High doses of fish oil might also reduce the immune system's activity, reducing the body's ability to fight 
infection. This is a special concern for people taking medications to reduce their immune system's activity 
(organ transplant patients, for example) and the elderly.  
Fish oil can cause side effects including belching, bad breath, heartburn, nausea, loose stools, rash, and 
nosebleeds. Taking fish oil supplements with meals or freezing them can often decrease these side 
effects.  
Bipolar disorder: Taking fish oil might increase some of the symptoms of this condition.  
 
Liver disease: Fish oil might increase the risk of bleeding in people with liver scarring due to liver 
disease.  
 
Depression: Taking fish oil might increase some of the symptoms of this condition.  
 
Diabetes: There is some concern that taking high doses of fish oil might make the control of blood sugar 
more difficult.  
High blood pressure: Fish oil can lower blood pressure and might cause blood pressure to drop too low 
in people who are being treated with blood pressure-lowering medications.  
Fish or seafood allergy: Some people who are allergic to seafood such as fish might also be allergic to 
fish oil supplements. There is no reliable information showing how likely people with seafood allergy are 
to have an allergic reaction to fish oil. Until more is known, advise patients allergic to seafood to avoid or 
use fish oil supplements cautiously.  
O3FA Uses 
Effective for:  High triglycerides. Research suggests that fish oil from supplements and food sources can 
reduce triglyceride levels. 
Likely Effective for:  Heart disease. Research suggests that eating fish can be effective for keeping 
people with healthy hearts free of heart disease. People who already have heart disease might also be able 
to lower their risk of dying from heart disease by eating fish or taking a fish oil supplement. 
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APPENDIX C 
TABLES & FIGURES 
Table 1  
Summary of Demographics 
Variable Mean ± SD 
Age (years) 20.0 ± 1.6 
Weight (kg) 89.5 ± 16.3  
Height (cm) 179.3 ± 2.9 
SD indicated Standard Deviation 
 
 
 
 
 
 
 
 
 
Note: Values shown represent mean ± standard deviation 
 
Note: Values shown represent mean ± standard deviation 
 
 
Table 5 
Difference in Number of Repetitions between Conditions 
  Number of Repetitions p-value 
Control 14 ± 11 0.19 
O3FA 6 ± 12   
Note: Values shown represent mean ± standard deviation 
 
Table 2  
Change in 24 Hour Perceived Soreness between Conditions 
  Perceived Soreness p-value 
Control 16.6 ± 27.4 0.72 
 
O3FA 19.7 ± 17.4  
Note: Values shown represent mean ± standard deviation 
 
 
Table 3  
24 Hour Perceived Soreness between Conditions 
 Perceived Soreness p-value 
Control 33.7 ± 17.6 0.47 
 
O3FA 26.8 ± 21.0  
 
Table 4 
Difference in Number of Repetitions 
  Test 1 Test 2 p-value 
Control 105 ± 20 90 ± 24 0.01 
O3FA 101 ± 17 96 ± 17 0.16 
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Table 6 
Rating of Perceived Exertion between Conditions 
  Median IQR p-value 
Control 
O3FA 
7.0  
6.0 
4.0 
4.0 0.88 
Note: p-values for differences are from Wilcoxon signed-rank test (N=10) 
 
Table 7 
Perceived Recovery Status  
 
  
Median IQR p-value 
Control 6.0 4 0.38 
O3FA 4.0 4.5 
 
Note: p-values for differences are from Wilcoxon signed-rank test (N=10) 
 
Table 8 
Nutrient Intake       
  Control O3FA p-value 
Energy (kcal) 5,547.7 ± 1,705.2 4,972.1 ± 1,709.8 0.25 
Fat (g) 253.5 ± 81.4 215 ± 87.7 0.08 
Carbohydrates (g) 
Median 
IQR 
587.0  
179.0 
518.0 
306.8 
0.51 
  
Protein (g) 
Median 
IQR 
221.0 
172.3 
237.5  
180.8 
0.83 
  
Note: p-values for carbohydrates and protein intake are from Wilcoxon signed-rank test (n=10) 
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FIGURES 
Figure 1  
Total Repetitions 
 
Figure 2 
Difference in Total Number of Repetitions 
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Figure 3 
Ratings of Perceived Exertion  
 
Figure 4 
Perceived Recovery 
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